A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/57 (2006.01) A61K 9/00 (2006.01) A61K 9/70 (2006.01) A61K 31/567 (2006.01) A61P 15/18 (2006.01)
Patent
CA 2478165
A method of contraception is disclosed comprising the step of administering to a menstruating female a cycle of contraceptive therapy, said cycle of therapy including the continuous administration for the length of the cycle of a potent sulfatase inhibiting progestogen in a contraceptively effective and breast protecting dose, in the absence of the administration of an estrogen.
La présente invention concerne une méthode de contraception qui comprend une étape d'administration d'un cycle de thérapie contraceptive à une femme menstruée, ledit cycle de thérapie comprenant l'administration continue sur la longueur du cycle d'un puissant progestogène inhibant la sulfatase, avec une dose protégeant les seins des carcinomes et efficace du point de vue contraceptif, en l'absence de l'administration d'un oestrogène.
Caubel Patrick Michel
Friedman Andrew Joseph
Janssen Pharmaceutica N.v.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Sulfatase inhibiting progestogen-only contraceptive regimens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfatase inhibiting progestogen-only contraceptive regimens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfatase inhibiting progestogen-only contraceptive regimens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1905421